The English text is an unofficial translation. In case of any
discrepancies between the Swedish text and the English translation,
the Swedish text shall prevail.
LUND,
Sweden, Aug. 6, 2024 /PRNewswire/ -- The
shareholders of Enzymatica AB (publ) (the "Company") held an
extraordinary general meeting on 6 August
2024. At the extraordinary general meeting, the following
resolutions, amongst others, were made.
Approval of the board of directors' resolution on a rights
issue of new shares
The meeting resolved to approve the board of directors'
resolution from 18 July 2024, to
increase the Company's share capital by a maximum amount of
SEK 2,774,117.32 through the issue of
a maximum number of 69,352,888 shares.
The shareholders of the Company shall have preferential rights
to subscribe for the new shares in relation the number of shares
previously held. For each share held on the record date, the
shareholder receives one subscription right, whereby five (5)
subscription rights entitle to subscribe for two (2) new
shares.
The record date for determining which shareholders shall be
entitled to subscribe for new shares on a preferential basis shall
be 26 August 2024.
The subscription price is SEK 1.90
per share which in the case of full subscription provides issuing
proceeds of up to approximately MSEK 131.8.
Subscription for new shares by exercise of subscription rights
shall be made by simultaneously cash payment during the period as
from 28 August 2024 up to and
including 11 September 2024.
Subscription for new shares without the exercise of subscription
rights shall take place during the same period on a separate
subscription list. Payment for new shares subscribed for without
the exercise of subscription rights shall be made in cash no later
than on the second bank day from dispatch of the contract note
setting forth the allotment of shares.
Trading with subscription rights will take place during the
period from 28 August 2024 until, and
including 6 August 2024. Trading in
BTA (Paid Subscribed Shares) will take place from 28 August 2024 until and including around 20
September 2024.
For more detailed information regarding the content of the
resolutions, please refer to the complete notice of the
extraordinary general meeting and the Company's website,
www.enzymatica.com.
For more information, please contact:
Claus Egstrand,
CEO, Enzymatica AB
Phone: +44 7780 22 8385 |
Email: claus.egstrand@enzymatica.com
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/enzymatica-ab/r/bulletin-from-the-extraordinary-general-meeting-of-enzymatica-ab--publ--on-6-august-2024,c4021627
The following files are available for download:
https://mb.cision.com/Main/18091/4021627/2934994.pdf
|
Press release
(PDF)
|
View original
content:https://www.prnewswire.co.uk/news-releases/bulletin-from-the-extraordinary-general-meeting-of-enzymatica-ab-publ-on-6-august-2024-302215545.html